Drug utilization research in Europe

Marion Bennie; Lotte Rasmussen; Janne Sepp

doi:10.1002/9781119911685.ch60

Drug utilization research in Europe

Marion Bennie^*, Lotte Rasmussen, Janne Sepp

^*Kontaktforfatter

Publikation: Kapitel i bog/rapport/konference-proceeding › Kapitel i bog › Forskning › peer review

Abstract

The health systems, healthcare expenditure models, and health outcomes vary considerably across the World Health Organization (WHO) Europe Region. This chapter illustrates some of the drug utilization research (DUR) communities across WHO Europe. It presents a list of communities across Europe supporting general DUR. The chapter presents a case study on Danish health system and Estonian health care system. The Danish National Prescription Registry is the most important data source for DUR and holds individual-level data on all medicines dispensed at Danish community pharmacies since 1995. The Estonian State Agency of Medicines is responsible for the supervision of the pharmaceutical sector and medicines in Estonia as well as promoting the rational use of medicines. Patient-level anonymized data about prescription medicines is administered by the Estonian Health Insurance Fund. All patients have a unique personal identification number within the Estonian health system.

Originalsprog	Engelsk
Titel	Drug Utilization Research : Methods and Applications
Redaktører	Monique Elseviers, Björn Wettermark, Ria Benkó, Marion Bennie, Katarina Gvozdanović, Mikael Hoffmann, Irina Iaru, Verica Ivanovska, Seán Macbride-Stewart, Tanja Mueller, Elisabetta Poluzzi, Lisa Pont, Helge Salvesen Blix, Gabriel Sanfélix-Gimeno, Gisbert Selke, Katja Taxis, Ana Tomas Petrović, Indrė Trečiokienė, Sabine Vogler
Forlag	Wiley
Publikationsdato	2024
Udgave	Second
Sider	574-579
Kapitel	4.8
ISBN (Trykt)	9781119911654
ISBN (Elektronisk)	9781119911685
DOI	https://doi.org/10.1002/9781119911685.ch60
Status	Udgivet - 2024

Dokumenter og links

10.1002/9781119911685.ch60

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Bennie, M., Rasmussen, L., & Sepp, J. (2024). Drug utilization research in Europe. I M. Elseviers, B. Wettermark, R. Benkó, M. Bennie, K. Gvozdanović, M. Hoffmann, I. Iaru, V. Ivanovska, S. Macbride-Stewart, T. Mueller, E. Poluzzi, L. Pont, H. S. Blix, G. Sanfélix-Gimeno, G. Selke, K. Taxis, A. T. Petrović, I. Trečiokienė, & S. Vogler (red.), Drug Utilization Research: Methods and Applications (Second udg., s. 574-579). Wiley. https://doi.org/10.1002/9781119911685.ch60

Bennie, Marion ; Rasmussen, Lotte ; Sepp, Janne. / Drug utilization research in Europe. Drug Utilization Research: Methods and Applications. red. / Monique Elseviers ; Björn Wettermark ; Ria Benkó ; Marion Bennie ; Katarina Gvozdanović ; Mikael Hoffmann ; Irina Iaru ; Verica Ivanovska ; Seán Macbride-Stewart ; Tanja Mueller ; Elisabetta Poluzzi ; Lisa Pont ; Helge Salvesen Blix ; Gabriel Sanfélix-Gimeno ; Gisbert Selke ; Katja Taxis ; Ana Tomas Petrović ; Indrė Trečiokienė ; Sabine Vogler. Second. udg. Wiley, 2024. s. 574-579

@inbook{d9553e722ffa478c98adad48f1a30b87,

title = "Drug utilization research in Europe",

abstract = "The health systems, healthcare expenditure models, and health outcomes vary considerably across the World Health Organization (WHO) Europe Region. This chapter illustrates some of the drug utilization research (DUR) communities across WHO Europe. It presents a list of communities across Europe supporting general DUR. The chapter presents a case study on Danish health system and Estonian health care system. The Danish National Prescription Registry is the most important data source for DUR and holds individual-level data on all medicines dispensed at Danish community pharmacies since 1995. The Estonian State Agency of Medicines is responsible for the supervision of the pharmaceutical sector and medicines in Estonia as well as promoting the rational use of medicines. Patient-level anonymized data about prescription medicines is administered by the Estonian Health Insurance Fund. All patients have a unique personal identification number within the Estonian health system.",

keywords = "Danish health system, Danish National Prescription Registry, Drug utilization research, Estonian health care system, Estonian Health Insurance Fund, Estonian State Agency of Medicines, Who Europe region",

author = "Marion Bennie and Lotte Rasmussen and Janne Sepp",

year = "2024",

doi = "10.1002/9781119911685.ch60",

language = "English",

isbn = "9781119911654",

pages = "574--579",

editor = "Monique Elseviers and Bj{\"o}rn Wettermark and Ria Benk{\'o} and Marion Bennie and Katarina Gvozdanovi{\'c} and Mikael Hoffmann and Irina Iaru and Verica Ivanovska and Se{\'a}n Macbride-Stewart and Tanja Mueller and Elisabetta Poluzzi and Lisa Pont and Blix, {Helge Salvesen} and Gabriel Sanf{\'e}lix-Gimeno and Gisbert Selke and Katja Taxis and Petrovi{\'c}, {Ana Tomas} and Indrė Tre{\v c}iokienė and Sabine Vogler",

booktitle = "Drug Utilization Research",

publisher = "Wiley",

address = "United Kingdom",

edition = "Second",

}

Bennie, M, Rasmussen, L & Sepp, J 2024, Drug utilization research in Europe. i M Elseviers, B Wettermark, R Benkó, M Bennie, K Gvozdanović, M Hoffmann, I Iaru, V Ivanovska, S Macbride-Stewart, T Mueller, E Poluzzi, L Pont, HS Blix, G Sanfélix-Gimeno, G Selke, K Taxis, AT Petrović, I Trečiokienė & S Vogler (red), Drug Utilization Research: Methods and Applications. Second udg, Wiley, s. 574-579. https://doi.org/10.1002/9781119911685.ch60

Drug utilization research in Europe. / Bennie, Marion; Rasmussen, Lotte; Sepp, Janne.
Drug Utilization Research: Methods and Applications. red. / Monique Elseviers; Björn Wettermark; Ria Benkó; Marion Bennie; Katarina Gvozdanović; Mikael Hoffmann; Irina Iaru; Verica Ivanovska; Seán Macbride-Stewart; Tanja Mueller; Elisabetta Poluzzi; Lisa Pont; Helge Salvesen Blix; Gabriel Sanfélix-Gimeno; Gisbert Selke; Katja Taxis; Ana Tomas Petrović; Indrė Trečiokienė; Sabine Vogler. Second. udg. Wiley, 2024. s. 574-579.

Publikation: Kapitel i bog/rapport/konference-proceeding › Kapitel i bog › Forskning › peer review

TY - CHAP

T1 - Drug utilization research in Europe

AU - Bennie, Marion

AU - Rasmussen, Lotte

AU - Sepp, Janne

PY - 2024

Y1 - 2024

N2 - The health systems, healthcare expenditure models, and health outcomes vary considerably across the World Health Organization (WHO) Europe Region. This chapter illustrates some of the drug utilization research (DUR) communities across WHO Europe. It presents a list of communities across Europe supporting general DUR. The chapter presents a case study on Danish health system and Estonian health care system. The Danish National Prescription Registry is the most important data source for DUR and holds individual-level data on all medicines dispensed at Danish community pharmacies since 1995. The Estonian State Agency of Medicines is responsible for the supervision of the pharmaceutical sector and medicines in Estonia as well as promoting the rational use of medicines. Patient-level anonymized data about prescription medicines is administered by the Estonian Health Insurance Fund. All patients have a unique personal identification number within the Estonian health system.

AB - The health systems, healthcare expenditure models, and health outcomes vary considerably across the World Health Organization (WHO) Europe Region. This chapter illustrates some of the drug utilization research (DUR) communities across WHO Europe. It presents a list of communities across Europe supporting general DUR. The chapter presents a case study on Danish health system and Estonian health care system. The Danish National Prescription Registry is the most important data source for DUR and holds individual-level data on all medicines dispensed at Danish community pharmacies since 1995. The Estonian State Agency of Medicines is responsible for the supervision of the pharmaceutical sector and medicines in Estonia as well as promoting the rational use of medicines. Patient-level anonymized data about prescription medicines is administered by the Estonian Health Insurance Fund. All patients have a unique personal identification number within the Estonian health system.

KW - Danish health system

KW - Danish National Prescription Registry

KW - Drug utilization research

KW - Estonian health care system

KW - Estonian Health Insurance Fund

KW - Estonian State Agency of Medicines

KW - Who Europe region

U2 - 10.1002/9781119911685.ch60

DO - 10.1002/9781119911685.ch60

M3 - Book chapter

AN - SCOPUS:85211882723

SN - 9781119911654

SP - 574

EP - 579

BT - Drug Utilization Research

A2 - Elseviers, Monique

A2 - Wettermark, Björn

A2 - Benkó, Ria

A2 - Bennie, Marion

A2 - Gvozdanović, Katarina

A2 - Hoffmann, Mikael

A2 - Iaru, Irina

A2 - Ivanovska, Verica

A2 - Macbride-Stewart, Seán

A2 - Mueller, Tanja

A2 - Poluzzi, Elisabetta

A2 - Pont, Lisa

A2 - Blix, Helge Salvesen

A2 - Sanfélix-Gimeno, Gabriel

A2 - Selke, Gisbert

A2 - Taxis, Katja

A2 - Petrović, Ana Tomas

A2 - Trečiokienė, Indrė

A2 - Vogler, Sabine

PB - Wiley

ER -

Bennie M, Rasmussen L, Sepp J. Drug utilization research in Europe. I Elseviers M, Wettermark B, Benkó R, Bennie M, Gvozdanović K, Hoffmann M, Iaru I, Ivanovska V, Macbride-Stewart S, Mueller T, Poluzzi E, Pont L, Blix HS, Sanfélix-Gimeno G, Selke G, Taxis K, Petrović AT, Trečiokienė I, Vogler S, red., Drug Utilization Research: Methods and Applications. Second udg. Wiley. 2024. s. 574-579 doi: 10.1002/9781119911685.ch60

Drug utilization research in Europe

Abstract

Dokumenter og links

SDU link

Fingeraftryk

Citationsformater